Back to search
FDAFDA · Food and drugs·Recall number D-0822-2026

Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc., Princeton, NJ 08540 NDC 69452-206-20.

Published September 9, 2026 · Recall initiated: August 7, 2026

Summary

FDA records drug Class III recall D-0822-2026, published September 9, 2026 and initiated August 7, 2026. Recalling firm: Bionpharma Inc.; Status: Ongoing; Reported quantity: 14,232 bottles (1,423,200 tablets); Lot: Lot # DMA25006, Exp Date: 11/30/2028. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
Manufacturer
Bionpharma Inc.
Distributor
US Nationwide.
Lot
Lot # DMA25006, Exp Date: 11/30/2028.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc., Princeton, NJ 08540 NDC 69452-206-20. recalled?

Yes. FDA published recall D-0822-2026 on September 9, 2026. Reported hazard: Presence of Foreign Tablets/Capsules

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE.